Related Experiment Video
Updated: Jan 3, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Chemokine regulation of inflammation during respiratory syncytial virus infection
Rinat Nuriev1,2, Cecilia Johansson1
1National Heart and Lung Institute, Imperial College London, London, UK.
Insights
Respiratory syncytial virus (RSV) causes severe lung infections, particularly in vulnerable groups. This review explores how chemokines regulate immune responses and inflammation during RSV infection.
Area of Science:
- Immunology
- Virology
- Respiratory Medicine
Background:
- Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections and infant hospitalizations globally.
- Immune responses are vital for controlling RSV but can lead to immunopathology if dysregulated.
- Lung immunity initiation involves immune cell recruitment to the lungs.
Purpose of the Study:
- To review recent advances in understanding RSV infection and disease.
- To focus on the role of chemokines in regulating virus-induced inflammation in the lungs.
Main Methods:
- Literature review of recent advances in RSV research.
- Focus on the mechanisms of chemokine-mediated immune cell recruitment.
Main Results:
- Chemokines are key regulators of inflammation during RSV infection.
- Chemokines orchestrate the recruitment of various leukocytes to the lungs.
- Dysregulated chemokine activity can contribute to RSV-associated immunopathology.
Conclusions:
- Understanding chemokine function is crucial for managing RSV-induced lung inflammation.
- Targeting chemokines may offer therapeutic strategies for severe RSV disease.
Abstract:
Respiratory syncytial virus (RSV) can cause severe lower respiratory tract infections especially in infants, immunocompromised individuals and the elderly and is the most common cause of infant hospitalisation in the developed world. The immune responses against RSV are crucial for viral control and clearance but, if dysregulated, can also result in immunopathology and impaired gas exchange. Lung immunity to RSV and other respiratory viruses begins with the recruitment of immune cells from the bloodstream into the lungs. This inflammatory process is controlled largely by chemokines, which are small proteins that are produced in response to innate immune detection of the virus or the infection process. These chemokines serve as chemoattractants for granulocytes, monocytes, lymphocytes and other leukocytes. In this review, we highlight recent advances in the field of RSV infection and disease, focusing on how chemokines regulate virus-induced inflammation.
More Related Videos
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Pneumonia II: Pathophysiology
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

